Augmented Renal Clearance
6
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance
Incidence and Associated Risk Factors of ARC in the Trauma Critically Ill Older Than 50 Years Old
Renal Function Assessment in Critically Ill Children
Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Augmented Renal Clearance
Detailed Assessment of Augmented Renal Clearance in a Large Mixed Intensive Care Unit Population
ARC in Hemorrhagic Stroke